Antifibrotic Drug Pirfenidone Cuts Lung Injury Risk in Immunotherapy-Treated Lung Cancer Patients
A phase II trial found that prophylactic pirfenidone significantly reduced grade 2 or higher radiation-induced lung injury in lung cancer ...
A phase II trial found that prophylactic pirfenidone significantly reduced grade 2 or higher radiation-induced lung injury in lung cancer ...
Researchers engineered anti-FAP-targeted exosomes loaded with pirfenidone and showed that nebulized delivery outperforms intravenous injection in treating pulmonary fibrosis in ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine